公开(公告)号：US20180215764A1

公开(公告)日：2018-08-02

申请号：US15852179

申请日：2017-12-22

Applicant: AbbVie Inc.

Inventor： Eric C. Breinlinger ,  Andrew Burchat ,  Justin D. Dietrich ,  Michael Friedman ,  David Ihle ,  David Kinsman ,  Kelly Mullen ,  Augustine T. Osuma ,  Anil Vasudevan ,  Noel S. Wilson

IPC: C07D487/04 ,  C07D519/00 ,  C07D498/04

CPC classification number: C07D487/04 ,  C07D498/04 ,  C07D519/00

Abstract: The disclosure provides compounds of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the disclosure are useful for treating immunological and oncological conditions.

公开(公告)号：US10273238B2

公开(公告)日：2019-04-30

申请号：US15852179

申请日：2017-12-22

Applicant: AbbVie Inc.

Inventor： Eric C. Breinlinger ,  Andrew Burchat ,  Justin Dietrich ,  Michael Friedman ,  David Ihle ,  David Kinsman ,  Kelly Mullen ,  Augustine Osuma ,  Anil Vasudevan ,  Noel S. Wilson

IPC: C07D487/04 ,  C07D519/00 ,  C07D498/04

Abstract: The disclosure provides compounds of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the disclosure are useful for treating immunological and oncological conditions.

公开(公告)号：US20160304526A1

公开(公告)日：2016-10-20

申请号：US15130323

申请日：2016-04-15

Applicant: AbbVie Inc.

Inventor： Eric Breinlinger ,  Andrew Burchat ,  Justin Dietrich ,  Michael Friedman ,  David Ihle ,  David Kinsman ,  Kelly Mullen ,  Augustine Osuma ,  Anil Vasudevan ,  Noel Wilson

IPC: C07D487/04 ,  C07D498/04 ,  C07D519/00

CPC classification number: C07D487/04 ,  C07D498/04 ,  C07D519/00

Abstract: The disclosure provides compounds of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the disclosure are useful for treating immunological and oncological conditions.

Abstract translation: 药学上可接受的盐，前药，生物活性代谢物，立体异构体和异构体，其中变量在本文中定义。 本公开的化合物可用于治疗免疫学和肿瘤学病症。

公开(公告)号：US09879016B2

公开(公告)日：2018-01-30

申请号：US15130323

申请日：2016-04-15

Applicant: AbbVie Inc.

Inventor： Eric Breinlinger ,  Andrew Burchat ,  Justin Dietrich ,  Michael Friedman ,  David Ihle ,  David Kinsman ,  Kelly Mullen ,  Augustine Osuma ,  Anil Vasudevan ,  Noel Wilson

IPC: C07D487/04 ,  C07D498/04 ,  C07D519/00

CPC classification number: C07D487/04 ,  C07D498/04 ,  C07D519/00

Abstract: The disclosure provides compounds of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the disclosure are useful for treating immunological and oncological conditions.